Lung Disease Clinical Trials
A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 1436 clinical trials
Pilot Study: Post-Recovery LibEration From Oxygen in Exacerbated COPD (RELIEF Pilot)
The investigators want to decrease inappropriate oxygen use for patients with COPD who have recovered from a recent hospitalization. The investigators are testing a new program that will stop oxygen prescriptions for patients that no longer need it and will instead provide them with training in skills that have been …
- 0 views
- 12 May, 2022
- 1 location
Internet-based Rehabilitation Aftercare Focusing on Physical Activity Promotion in Persons With COPD (COPD-AReNa)
The aim of the study is to evaluate a 12-week internet-based rehabilitation aftercare program with an emphasis on physical activity promotion for persons with COPD. The program starts directly after an inpatient pulmonary rehabilitation program. It includes monitoring and promotion of physical activity, progressive resistance and endurance training, education through …
- 0 views
- 13 May, 2022
A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer
The purpose of this study is to develop a digital strategy to increase awareness about lung cancer screening among women who are eligible to receive it. The digital strategy involves email
- 0 views
- 15 May, 2022
- 7 locations
A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer (FWD1509)
The purpose of this study is to characterize the safety and tolerability of FWD1509 MsOH in advanced NSCLC patients and establish the maximum tolerable dose (MTD), recommended phase 2 dose (RP2D) in advanced NSCLC patients.
- 0 views
- 19 Apr, 2022
- 1 location
SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage IB to III Non-small Cell Lung Cancer (SACTION01)
operable stage IB (tumors > 4cm) to III non-small cell lung cancer (NSCLC) prior to surgery.
- 0 views
- 26 Apr, 2022
- 1 location
A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer
participants with limited stage small cell lung cancer who have not progressed during/after chemoradiotherapy.
- 0 views
- 15 May, 2022
- 21 locations
Reqorsa (Quaratusugene Ozeplasmid) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib (Acclaim-1)
The purpose of this randomized study is to determine the safety and efficacy of Reqorsa (quaratusugene ozeplasmid, formerly known as GPX-001) added to osimertinib in NSCLC patients with activating EGFR mutations who have progressed while on treatment with osimertinib. Reqorsa consists of non-viral lipid nanoparticles that encapsulate a DNA plasmid …
- 0 views
- 01 May, 2022
- 4 locations
Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients (LUNG-RESIST)
Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI) are effective therapies for advanced lung cancer patients bearing EGFR-activating mutations, but are not curative due to
- 0 views
- 23 May, 2022
- 1 location
Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
Small Cell Lung cancer (SCLC) is a highly aggressive tumor that accounts for about 15 percent of all lung cancer cases. SCLC disease progresses rapidly, and about 2/3 of the patients have
- 0 views
- 23 Apr, 2022
- 1 location
Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma
therapy for resectable stage III EGFR mutation-positive lung adenocarcinoma.
- 0 views
- 08 Apr, 2022
- 1 location